Dr. A. Enrique Caballero is an Endocrinologist, Investigator and Educator. He is the Director of International Innovation Programs in the Office for External Education and the Director of Diabetes Education in the Postgraduate Medical Education Department at Harvard Medical School (HMS) where he leads the development of education programs that benefit health care professionals and patients around the world.  He is Associate Professor of Medicine at HMS. 

He is also the Director of Latino Diabetes Health in the Division of Endocrinology, Diabetes and Hypertension an Associate Scientist in the Division of Global Health Equity at the Brigham and Hospital (BWH) in Boston, MA. He is currently President of Medicine & Science for the American Diabetes Association’s (ADA) and a member of its Board of Directors. He is immediate past Chair of the Health Disparities Committee for the ADA and Co-chair for the Diabetes Working Group at the National Minority Quality Forum (NMQF)/Center for Sustainable Health Care Quality and Equity.

Dr. Caballero has had a strong and long commitment to help underserved populations. He founded the Latino Diabetes Initiative at the Joslin Diabetes Center and currently leads similar efforts at the BWH, both affiliated with HMS. He has been actively involved with the ADA, the Endocrine Society, the National Hispanic Medical Association, the NMQF, the American Association of Clinical Endocrinologists (AACE), the Latin American Diabetes Association and the International Diabetes Federation.   

His research interests include type 2 diabetes, obesity and cardiovascular disease (CVD) prevention and management, particularly in high-risk populations by virtue of racial/ethnic background and/or socio-economic factors. He has been a co-investigator of the National Diabetes Prevention Program, the LookAhead Program and the Diabetes Education Study, all sponsored by the NIH.  

Dr. Caballero has written numerous publications on how diabetes affects the Latino/Hispanic community, diabetes management and prevention, obesity, and diabetes and CVD.  He is also a reviewer for multiple prestigious medical journals and is Associate Editor for Diabetes Research and Clinical Practice, the official journal of the International Diabetes Federation. 

Dr. Caballero graduated from the National University of Mexico Medical School where he was awarded with the “Gabino Barreda” medal for being the top student and achieving the highest academic level his class. After completing his training in Internal Medicine, Endocrinology and Clinical Epidemiology in Mexico, he completed a fellowship program in Endocrinology and Metabolism at the Lahey Clinic/Deaconess Hospital/Joslin Diabetes Center in Boston and the Program on Clinical Effectiveness at the Harvard School of Public Health.   

He has received local, regional, national and international recognitions and awards.  Dr. Caballero is the recipient of the 2009 “Alberto Houssay” award by the National Minority Quality Forum, the 2011 award by the American Association of Clinical Endocrinologists for his work on health care disparities and with underserved populations and the 2012 Distinguished Community Service and Leadership Award by ALPFA Health Care.  Dr. Caballero was recently named an honorary member of the Dominican Republic Endocrinology and Nutrition Society for his contributions to the Hispanic/Latino community. He also received a special recognition from the government of Mexico for his continuous effort and commitment to help underserved populations.  He is the recipient of the 2022 Harvard Medical School Harold Amos prestigious award that recognizes exemplary work on Diversity, Inclusion and Equity in Health Care.  He is the recipient of the 2023 American Diabetes Association’s Outstanding Educator in Diabetes Award and the 2024 Endocrine Society’s Outstanding Educator Award.